Chancellor Rachel Reeves Plans Targeted Measures on Bills in Forthcoming Financial Plan
Treasury head Reeves has stated she is planning "specific steps to address cost of living challenges" in next month's financial statement.
During an interview with the BBC, she stated that reducing price rises is a joint responsibility of both the government and the central bank.
The UK's inflation rate is forecast to be the highest among the Group of Seven industrialized countries this year and next.
Potential Energy Cost Interventions
It is understood the government could intervene to reduce utility costs, such as by slashing the current 5% level of VAT applied on energy.
Another option is to cut some of the policy costs currently included in household expenses.
Fiscal Constraints and Analyst Expectations
The administration will obtain the next draft from the independent fiscal watchdog, the OBR, on Monday, which will clarify how much scope there is for these actions.
The expectation from the majority of analysts is that the Chancellor will have to introduce tax increases or expenditure reductions in order to fulfill her voluntary fiscal targets.
Earlier on the same day, estimates suggested there was a twenty-two billion pound gap for the chancellor to resolve, which is at the more modest range of projections.
"It is a shared responsibility between the Bank of England and the government to bear down further on some of the causes of price increases," the Chancellor stated to reporters in the US capital, at the annual meetings of the International Monetary Fund and global financial institution.
Revenue Pledges and International Issues
While a great deal of the attention has been on expected tax increases, the chancellor said the latest figures from the fiscal watchdog had not altered her vow to election pledges not to raise tax levels on income tax, sales tax or National Insurance.
She blamed an "uncertain world" with rising international and commercial concerns for the Budget tax moves, likely to be focused on those "with the broadest shoulders."
International Trade Tensions
Commenting on concerns about the UK's commercial links with China she said: "Our security interests always come first."
Last week's declaration by Chinese authorities to tighten export controls on rare earths and other resources that are essential for advanced tech production led US President Donald Trump to threaten an extra 100% tariff on imports from China, increasing the risk of an all-out commercial conflict between the two global powers.
The American finance chief called China's action "economic coercion" and "a international production control attempt."
Asked about considering the US offer to join its dispute with the Asian nation, the Chancellor said she was "very concerned" by China's measures and encouraged the Chinese government "not to put up barriers and limit trade."
She said the action was "harmful for the global economy and creates further headwinds."
"I believe there are sectors where we must confront Chinese policies, but there are also important opportunities to trade with China's economy, including financial services and other areas of the economy. We've got to achieve that balance appropriate."
The Treasury chief also stated she was working with international partners "on our own essential resources approach, so that we are more independent."
Health Service Medicine Costs and Funding
The Chancellor also recognized that the cost the NHS pays for medicines could go up as a consequence of ongoing discussions with the US government and its drugs companies, in exchange for lower tariffs and capital.
Some of the biggest global drug companies have said in recent statements that they are either delaying or canceling investments in the UK, with some attributing the modest returns they are obtaining.
Recently, the Science Minister said the cost the NHS pays for drugs would need to rise to stop businesses and drug research funding departing from the United Kingdom.
The Chancellor stated to the BBC: "It has been observed due to the cost structure, that clinical trials, recent pharmaceuticals have not been provided in the UK in the extent that they are in other EU nations."
"We want to make sure that individuals receiving care from the NHS are able to receive the best essential medicines in the world. And so we are examining all of that, and... looking to attract more investment into the UK."